Division of Pediatric Hematology and Oncology

September 18, 2017

New cutting-edge treatment for type of pediatric leukemia offered at Monroe Carell Jr. Children’s Hospital at Vanderbilt 

By Christina Echegaray
August 24, 2017

Hyundai Hope on Wheels award boosts pediatric cancer research

Adam Esbenshade, M.D., MSCI, assistant professor of Pediatrics in the Division of Pediatric Hematology/Oncology, has been awarded a $50,000 Hyundai Hope on Wheels Impact Award. Esbenshade plans to use data to create a risk prediction model to predict blood stream infections in pediatric cancer patients.

By Christina Echegaray
June 8, 2017

Friends of Children’s Hospital gift to enhance two programs

The Friends of Children’s Hospital, an organization of volunteers who support Monroe Carell Jr. Children’s Hospital at Vanderbilt, has made its largest single gift — $1 million over three years — to be split between two Children’s Hospital programs: the Program for Children with Medically Complex Needs and Pediatric Cancer.

By Nancy Humphrey
young african american man in hospital
February 22, 2017

Risk of death in sickle cell disease

Two factors commonly used to evaluate patients with sickle cell disease are associated with each other and can predict increased mortality, Vanderbilt researchers have discovered.

By Meredith Jackson
February 18, 2016

Pediatrics awarded physician-scientist training support

The National Institutes of Health (NIH) has awarded Vanderbilt’s Department of Pediatrics a K12 training grant to support early career faculty to become physician-scientists, the first time the department has received such an award.

By Matt Batcheldor
July 30, 2015

Hyundai Hope On Wheels bolsters pediatric cancer fight

Debra Friedman, M.D., director of Pediatric Hematology/Oncology and E. Bronson Ingram Professor of Pediatric Oncology, has received a $50,000 Hyundai Hope On Wheels Impact grant recently for her track record in providing excellent patient care to families affected by pediatric cancer and to support a pediatric cancer program aimed at developing innovative therapies.

By Christina Echegaray
July 16, 2015

Kitko to lead Pediatric Stem Cell Transplant Program

Carrie Kitko, M.D., has joined Monroe Carell Jr. Children’s Hospital at Vanderbilt as associate professor of Pediatrics and director of the Pediatric Stem Cell Transplant Program in the Division of Hematology/Oncology.
By Christina Echegaray
June 9, 2015

Retreat highlights pediatrics research at Vanderbilt

Every day, physicians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are looking for new and effective ways to care for their patients. Often that mission is carried out through clinical, basic and translational research across the institution and disciplines.
By Christina Echegaray
October 16, 2014

DeBaun’s Levi Watkins Lecture highlights the power of purpose

Throughout his career in medicine, Michael R. DeBaun, M.D., has found moments to fight the status quo.
By VUMC News and Communications
October 9, 2014

Vanderbilt’s DeBaun to deliver annual Levi Watkins Jr. Lecture

Michael R. DeBaun, M.D., J.C. Peterson Professor of Pediatrics and Medicine at Vanderbilt, will be the keynote speaker at the 13th Annual Levi Watkins Jr. Lecture.
By Jessica Pasley
October 2, 2014

Program focuses on heart health of cancer patients

The Vanderbilt Cardio-Oncology program has fostered a special collaborative relationship combining the expertise of cardiologists and oncologists to understand the effects of cancer therapy on the heart. This type of collaboration is now helping to define the cardiovascular health of more than 14 million cancer survivors in the United States.
By Kathy Whitney
September 18, 2014

Predators support powers pediatric cancer programs

The Nashville Predators Foundation recently presented a $318,242 check to Monroe Carell Jr. Children’s Hospital at Vanderbilt for the 365 Pediatric Cancer Fund.
By Christina Echegaray
August 21, 2014

Transfusions ease strokes for children with sickle cell

Vanderbilt-led research found regular blood transfusion therapy significantly reduces the recurrence of strokes in children with sickle cell anemia who have previously had "silent" strokes.
By Christina Echegaray
1 2 3 4